School Event Request Form

A new drug for prostate cancer, which delivers a precisely targeted dose of radiation to cancer cells, can keep cancer at bay, a phase I trial reports.

In a significant advancement, cancer researchers have found a long-sought way to overcome a critical design barrier in the generation of small-molecule chemical tools and drugs that work by targeted protein degradation.

Researchers from The Institute of Cancer Research, London, attended a prestigious ceremony at St James’s Palace today to mark the formal presentation of the Queen Elizabeth Prize for Higher and Further Education (previously known as the Queen’s Anniversary Prize).

Researchers have shown that subtle mutational differences in a gene called ATRX help explain why children with the same type of neuroblastoma respond differently to treatment. These findings could support precise therapy recommendations based on a stronger understanding of the disease’s underlying biology.